FDA’s Labeling Rule Should Be Tweaked, Firms Say; Dems Want It Squashed
Executive Summary
FDA appears to have a relatively smooth task ahead of itself as it works to finalize its proposed rule delineating when firms can change product labels without prior agency approval since the comments supporting the proposal contain few suggested changes
You may also be interested in...
No Dispute Over Safety-Related Label Updates; Does FDA Hold All The Cards?
A new dispute resolution process for product labeling updates may see little action given the drug safety liability pressures from outside FDA, Lauren Silvis, an associate in Sidley Austin's Food and Drug Practice, said
No Dispute Over Safety-Related Label Updates; Does FDA Hold All The Cards?
A new dispute resolution process for product labeling updates may see little action given the drug safety liability pressures from outside FDA, Lauren Silvis, an associate in Sidley Austin's Food and Drug Practice, said
FDA’s Office of Chief Counsel Is Growing Its Ranks As It Amends Its Act
Tucked away on the sixth floor of the Parklawn Building in Rockville, FDA's Office of Chief Counsel is calm and quiet. Beneath the surface, however, there is a surge of activity. One of the main engines driving the agency, the 80-lawyer shop helps craft regulations, manages dozens of lawsuits and oversees every enforcement action